This inventor holds 2 USPTO granted patents. Top assignee: Genentech, Inc.. Active years: 1992-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992-1996
Title: Marjorie A Mohler: Innovator in Therapeutic Compositions
Introduction
Marjorie A Mohler is a distinguished inventor based in Oakland, CA. She has made significant contributions to the field of therapeutic compositions, holding 2 patents that showcase her innovative spirit and dedication to advancing medical science.
Latest Patents
Her latest patents include a method and therapeutic compositions for the prevention of fibrin. This invention involves a pharmaceutical composition that prevents fibrin deposition or adhesion formation through the topical application of a sparingly soluble enzyme. This enzyme is designed to be continuously released at the application site for a duration of three days to two weeks, potentially including an inert adherence enhancing vehicle. Another notable patent is a novel assay system for measuring human plasminogen actuator activity. This system selectively inhibits human tissue plasminogen activator using a thrombin inhibitor, specifically illustrated by D-Phe-Pro-Arg-chloromethyl ketone (PPACK), providing a new method for measuring human tissue plasminogen activator activity.
Career Highlights
Marjorie currently works at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work at Genentech has allowed her to collaborate with other talented professionals in the field.
Collaborations
Some of her notable coworkers include Adair J Hotchkiss and Tue H Nguyen, who contribute to the collaborative environment that fosters innovation and research excellence.
Conclusion
Marjorie A Mohler's contributions to therapeutic compositions and her innovative patents reflect her commitment to improving medical treatments. Her work continues to inspire advancements in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
